CELLIGENICS ENABLING CELLULAR THERAPEUTICS
LIVE

Serial Number

79269809

Owner

Celligenics Pte. Ltd.

Attorney

David J. Byer

Filing Date

Jun 17, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CELLIGENICS ENABLING CELLULAR THERAPEUTICS Trademark

Serial Number: 79269809 • Registration: 6150027

CELLIGENICS ENABLING CELLULAR THERAPEUTICS is a trademark filed by Celligenics Pte. Ltd. on June 17, 2019. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Celligenics Pte. Ltd. (2 trademarks)

25 North Bridge Road,

Entity Type: 16

Trademark Details

Filing Date

June 17, 2019

Registration Date

September 15, 2020

Published for Opposition

June 30, 2020

Goods & Services

Medical services; personal hygienic and beauty care for human beings; medical services relating to the removal, treatment and processing of stem cells; medical advisory services; medical analysis services for diagnostics and treatment purposes provided by medical laboratories; medical assistance services; medical care services; medical diagnostic services; medical information services; medical and healthcare services; medical testing for diagnostic or treatment purposes

Scientific and technological services and research and design relating thereto, namely, scientific research for product development in stem cell biology, stem cells and their derivatives, stem cell commercialization methods, ancillary techniques and cell manufacturing services; industrial analysis, namely, quality and performance profiling of stem cells and their derivatives for standards development, comparison to standards and industrial research services in the field of cell and molecular biology, stem cells and their derivatives, research and analysis for standards development and quality control; stem cell research; stem cell research services; medical research services; biological research services; pharmaceutical research services; scientific research services; medical laboratory services; biochemistry research services; scientific research and industrial research services in the field of stem cell biology for clinical, cosmeceutical and biotech applications; pharmaceutical research and development services; scientific research for medical purposes; scientific laboratory services; provision of information relating to scientific research; provision of information relating to technological research in the field of stem cell biology, stem cells and their derivatives, molecular and cell biology, immunology, cancer biology and methods of use of stem cells and their derivatives in clinical, cosmeceutical and biotech applications

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 15, 2025 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 12, 2022 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 4, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 4, 2021 FICS
FINAL DISPOSITION PROCESSED
Jan 4, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 15, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 15, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 30, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 30, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Jun 26, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 10, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 10, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 10, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 26, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
May 26, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 26, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
May 26, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 26, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 1, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 1, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 1, 2020 TROA
REFUSAL PROCESSED BY IB
Nov 22, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 5, 2019 RFCS
REFUSAL PROCESSED BY MPU
Nov 5, 2019 RFRR
APPLICATION FILING RECEIPT MAILED
Oct 24, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 21, 2019 RFCR
NON-FINAL ACTION WRITTEN
Oct 20, 2019 CNRT
ASSIGNED TO EXAMINER
Oct 20, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 20, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 17, 2019 REPR